BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Career Advice

  Logistical skills: The Panacea The Pharma Sector Needs

  With a swirl of rumors around the changes in ownership in the pharma industry, this invariably triggers reviews of business strategies. Because of this, wider skillsets from related sectors are needed.

  June 1, 2022

   · 

  4 min read

   · 

  Leigh Anderson
• 

  Drug Development

  Sage/Biogen Depression Drug Yields Positive Results in Postpartum Depression

  Sage Therapeutics and partner Biogen shared news that their phase III Skylark study has yielded promising results for women suffering from severe postpartum depression (PPD).

  June 1, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Business

  Report Predicts AbbVie Could Become Top-Selling Pharma Company by 2028

  The report suggests that AbbVie’s sales will be approximately $65.7 billion within the next six years, with Roche right behind at $65 billion.

  June 1, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Biopharma Companies Team Up to Fight Diabetes, Alzheimer’s and Cancer

  Several new biotech and biopharma companies are sharing their strengths to develop new treatments for high-need diseases diabetes, Alzheimer’s and cancer.

  June 1, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Business

  Gene-Editing the Microbiome: The Limitless Possibilities

  Eligo Bioscience has thought of a way to solve the dysbiosis between our bodies and our microbiomes – gene editing. BioSpace spoke with Eligo Co-founder and CEOXavier Duportet, Ph.D.

  June 1, 2022

   · 

  5 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Global Roundup: Memo Therapeutics Takes Aim at BKV Infections

  Biopharma and life sciences organizations from across the globe provide updates on their pipelines and businesses.

  June 1, 2022

   · 

  6 min read

   · 

  Alex Keown
• 

  Business

  AbbVie is Enabling Students Diagnosed with Immunological Diseases to Shine

  The AbbVie Immunology Scholarship provides financial support to students living with chronic, immune-mediated diseases who are pursuing higher education in the United States.

  June 1, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  Passage Bio CEO Bruce Goldsmith Abruptly Steps Down

  Although Bruce Goldsmith will no longer serve on the executive team, he will remain with Passage Bio for a short period as a strategic advisor to the interim CEO.

  June 1, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  BMS Preps Lupus Treatment to Become Third Approval in Space

  Bristol Myers Squibb (BMS) has announced late-breaking data showing deucravacitinib significant efficacy at the primary endpoint for the treatment of systemic lupus erythematosus (SLE).

  June 1, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Deals

  Pfizer to Sell Stake in Haleon Following GSK De-Merger

  Pfizer intends to sell off its stake when the de-merger occurs and seek the most profitable sale of its share of Haleon to maximize value for company stockholders.

  June 1, 2022

   · 

  2 min read

   · 

  Alex Keown